105 related articles for article (PubMed ID: 3365304)
1. Development of more selective anti-cancer nitrosoureas.
Eisenbrand G; Berger MR; Fischer J; Schneider MR; Tang W; Zeller WJ
Anticancer Drug Des; 1988 Mar; 2(4):351-9. PubMed ID: 3365304
[TBL] [Abstract][Full Text] [Related]
2. Novel steroid-linked conjugates of 17 beta-[N-[N'-(2-chloroethyl)-N'-nitroso]carbamoyl]amino acids and their antineoplastic activity against Noble Nb prostate carcinoma model in rats.
Tang W; Schneider MR; Eisenbrand G
Anticancer Drug Des; 1998 Oct; 13(7):815-24. PubMed ID: 9807164
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapeutic characterization of new nitrosourea compounds].
Zeller WJ; Berger MR; Eisenbrand G; Petru E
Arch Geschwulstforsch; 1988; 58(3):137-49. PubMed ID: 3415433
[TBL] [Abstract][Full Text] [Related]
4. A new comprehensive technique of catheterisation, blood sampling, sample preparation and sample analysis by means of high-pressure liquid chromatography for pharmacokinetic studies with estradiol-linked nitrosoureas and their metabolites.
Betsch B; Berger MR; Spiegelhalder B
Arzneimittelforschung; 1990 Sep; 40(9):1022-5. PubMed ID: 2080936
[TBL] [Abstract][Full Text] [Related]
5. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
Zeller WJ; Schreiber J; Petru E; Eisenbrand G
Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
Papageorgiou A; Lialiaris T; Stergiou E; Stergiou I; Tsigris C; Kourti A; Geromichalos G; Stravoravdi P; Trafalis D; Athanassiou AE; Pitsas A; Camoutsis Ch
J BUON; 2008; 13(2):235-9. PubMed ID: 18555471
[TBL] [Abstract][Full Text] [Related]
7. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
Eisenbrand G
IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-linked 2-chloroethylnitrosoureas: anticancer efficacy in MNU-induced rat mammary carcinoma, uterine activity in mice and receptor interactions.
Berger MR; Floride J; Schmähl D; Schreiber J; Eisenbrand G
Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1179-91. PubMed ID: 3816911
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cytosolic sexual steroid receptors in autochthonous methylnitrosourea-induced rat mammary carcinoma following application of 2-chloroethylnitrosocarbamoyl-L-alanine linked to oestradiol or dihydrotestosterone.
Corr R; Berger MR; Betsch B; Floride JA; Brix HP; Schmähl D
Br J Cancer; 1990 Jul; 62(1):42-7. PubMed ID: 2390481
[TBL] [Abstract][Full Text] [Related]
10. [In vitro study of estradiol-linked nitrosourea in breast cancers in the mouse, rat and human: interspecies comparison].
Petru E; Berger MR; Zeller WJ; Kaufmann M
Wien Klin Wochenschr; 1989 Feb; 101(4):130-4. PubMed ID: 2538970
[TBL] [Abstract][Full Text] [Related]
11. Androgen-linked alkylating agents: biological activity in methylnitrosourea-induced rat mammary carcinoma.
Brix HP; Berger MR; Schneider MR; Tang WC; Eisenbrand G
J Cancer Res Clin Oncol; 1990; 116(6):538-49. PubMed ID: 2254372
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)urea linked to 4-acetoxy-bisdesmethyltamoxifen, estradiol and dihydrotestosterone.
Kaleagasioglu F; Berger MR; Schmähl D; Eisenbrand G
Arzneimittelforschung; 1990 May; 40(5):603-6. PubMed ID: 2383304
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of new estrogen-linked 2-chloroethylnitrosoureas. I. Short term anticancer efficacy in methylnitrosourea-induced rat mammary carcinoma and hormonal activity in mice.
Berger MR; Floride J; Schreiber J; Schmähl D; Eisenbrand G
J Cancer Res Clin Oncol; 1984; 108(1):148-53. PubMed ID: 6746705
[TBL] [Abstract][Full Text] [Related]
14. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
15. Examination of newly synthesized 2-chloroethylnitrosoureas in preterminal leukemia L 5222 and in two transplanted neurogenic tumors.
Berger M; Zeller WJ; Eisenbrand G; Lin PZ; Nakra M; Schmähl D
Arzneimittelforschung; 1982; 32(5):481-4. PubMed ID: 6285938
[TBL] [Abstract][Full Text] [Related]
16. In vitro chemotherapy of steroid receptor positive human meningioma low-passage primary cultures with nitrosourea-methionine-steroid conjugates.
Taut FJ; Zeller WJ
Clin Neuropharmacol; 1996 Dec; 19(6):520-5. PubMed ID: 8937791
[TBL] [Abstract][Full Text] [Related]
17. In vitro cytotoxicity and differential cellular sensitivity of derivatives of diamino acids. II. N1-methyl, N1-allyl, N1-(2-chloroethyl) and N1-propargyl nitrosoureas.
Dulude H; Salvador R; Gallant G
Anticancer Res; 1995; 15(3):853-8. PubMed ID: 7645970
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of steroid-linked N-(2-chloroethyl)nitrosoureas.
Eisenbrand G; Fischer J; Mühlbauer K; Schied G; Schreiber J; Tang W; Zelezny O
Arch Pharm (Weinheim); 1989 Dec; 322(12):863-72. PubMed ID: 2619515
[TBL] [Abstract][Full Text] [Related]
19. Mutagenic activity of nitrosourea antitumor agents.
Franza BR; Oeschger NS; Oeschger MP; Schein PS
J Natl Cancer Inst; 1980 Jul; 65(1):149-54. PubMed ID: 6446611
[TBL] [Abstract][Full Text] [Related]
20. Drug design: nitrosoureas.
Eisenbrand G; Müller N; Schreiber J; Stahl W; Sterzel W; Berger MR; Zeller WJ; Fiebig H
IARC Sci Publ; 1986; (78):281-94. PubMed ID: 3583393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
